Q32 Bio Cash And Short Term Investments Over Time

QTTB Stock   25.44  0.89  3.63%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Q32 Bio Performance and Q32 Bio Correlation.
For information on how to trade Q32 Stock refer to our How to Trade Q32 Stock guide.
  
The current year's Cash And Short Term Investments is expected to grow to about 99.4 M.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Q32 Bio. If investors know Q32 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Q32 Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.50)
Revenue Per Share
(1.24)
The market value of Q32 Bio is measured differently than its book value, which is the value of Q32 that is recorded on the company's balance sheet. Investors also form their own opinion of Q32 Bio's value that differs from its market value or its book value, called intrinsic value, which is Q32 Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Q32 Bio's market value can be influenced by many factors that don't directly affect Q32 Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Q32 Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Q32 Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Q32 Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Cash And Short Term Investments Analysis

Compare Q32 Bio and related stocks such as National Beverage Corp, Anheuser Busch Inbev, and MYR Group Cash And Short Term Investments Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
FIZZ17.3 M35.6 M18.3 M29.9 M52.5 M105.6 M136.4 M189.9 M156.2 M304.5 M193.6 M48 M158.1 M327 M84.1 M
BUD258.1 M5.4 B13.9 B10 B8.7 BB14.2 B11.8 B7.2 B7.3 B15.6 B12.4 B10 B10.4 B7.6 B
MYRG5.2 M34 M19.8 M76.5 M77.6 M39.8 M23.8 M5.3 M7.5 M12.4 M22.7 M82.1 M51 M24.9 M25 M
FMX1.4 B27.7 B38.1 B27.4 B35.6 B29.4 B43.8 B99.1 B93 B77.9 B109 B121.8 B83.5 B191.8 B201.4 B
PKOH2.7 M78 M44.4 M55.2 M58 M62 M64.3 M82.8 M55.7 M56 M55 M54.1 M58.2 M54.8 M27.8 M
CHX10.4 M10.4 M10.4 M10.4 M10.4 M10.4 M26 M23.7 M41.8 M35.3 M201.4 M251.7 M250.2 M288.6 M303 M
PH18.4 M838.3 M1.8 B2.2 B1.9 B2.1 B924.2 M855.1 M3.4 B756.3 M772.2 M563.7 M483.6 M422 M584.3 M

Q32 Bio and related stocks such as National Beverage Corp, Anheuser Busch Inbev, and MYR Group Cash And Short Term Investments description

Short Term Investments is an account in the current assets section of Q32 Bio balance sheet. This account contains Q32 Bio investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Q32 Bio fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

My Equities

My Current Equities and Potential Positions

Q32 Bio
QTTB
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationMassachusetts; U.S.A
ExchangeNASDAQ Exchange
null 25.44
When determining whether Q32 Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Q32 Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Q32 Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Q32 Bio Stock:
Check out Q32 Bio Performance and Q32 Bio Correlation.
For information on how to trade Q32 Stock refer to our How to Trade Q32 Stock guide.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Q32 Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Q32 Bio technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Q32 Bio trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...